Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Manipulating Immune Activation of Macrophages by Tuning the Oligonucleotide Composition of Gold Nanoparticles.

Pallares RM, Choo P, Cole LE, Mirkin CA, Lee A, Odom TW.

Bioconjug Chem. 2019 Jul 17;30(7):2032-2037. doi: 10.1021/acs.bioconjchem.9b00316. Epub 2019 Jun 19.

PMID:
31243978
2.

Deciphering the domain specificity of C. difficile toxin neutralizing antibodies.

Cole LE, Li L, Jetley U, Zhang J, Pacheco K, Ma F, Zhang J, Mundle S, Yan Y, Barone L, Rogers C, Beltraminelli N, Quemeneur L, Kleanthous H, Anderson SF, Anosova NG.

Vaccine. 2019 Jun 27;37(29):3892-3901. doi: 10.1016/j.vaccine.2019.05.040. Epub 2019 May 20.

3.

Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.

Cole LE, McGinnity TL, Irimata LE, Vargo-Gogola T, Roeder RK.

Acta Biomater. 2018 Dec;82:122-132. doi: 10.1016/j.actbio.2018.10.014. Epub 2018 Oct 11.

PMID:
30316022
4.

Smaller CpG-Conjugated Gold Nanoconstructs Achieve Higher Targeting Specificity of Immune Activation.

Yue J, Pallares RM, Cole LE, Coughlin EE, Mirkin CA, Lee A, Odom TW.

ACS Appl Mater Interfaces. 2018 Jul 5;10(26):21920-21926. doi: 10.1021/acsami.8b06633. Epub 2018 Jun 21.

5.

Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.

Sita TL, Kouri FM, Hurley LA, Merkel TJ, Chalastanis A, May JL, Ghelfi ST, Cole LE, Cayton TC, Barnaby SN, Sprangers AJ, Savalia N, James CD, Lee A, Mirkin CA, Stegh AH.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4129-4134. doi: 10.1073/pnas.1702736114. Epub 2017 Apr 3.

6.

Denial of long-term issues with agriculture on tropical peatlands will have devastating consequences.

Wijedasa LS, Jauhiainen J, Könönen M, Lampela M, Vasander H, Leblanc MC, Evers S, Smith TE, Yule CM, Varkkey H, Lupascu M, Parish F, Singleton I, Clements GR, Aziz SA, Harrison ME, Cheyne S, Anshari GZ, Meijaard E, Goldstein JE, Waldron S, Hergoualc'h K, Dommain R, Frolking S, Evans CD, Posa MR, Glaser PH, Suryadiputra N, Lubis R, Santika T, Padfield R, Kurnianto S, Hadisiswoyo P, Lim TW, Page SE, Gauci V, Van Der Meer PJ, Buckland H, Garnier F, Samuel MK, Choo LN, O'Reilly P, Warren M, Suksuwan S, Sumarga E, Jain A, Laurance WF, Couwenberg J, Joosten H, Vernimmen R, Hooijer A, Malins C, Cochrane MA, Perumal B, Siegert F, Peh KS, Comeau LP, Verchot L, Harvey CF, Cobb A, Jaafar Z, Wösten H, Manuri S, Müller M, Giesen W, Phelps J, Yong DL, Silvius M, Wedeux BM, Hoyt A, Osaki M, Hirano T, Takahashi H, Kohyama TS, Haraguchi A, Nugroho NP, Coomes DA, Quoi LP, Dohong A, Gunawan H, Gaveau DL, Langner A, Lim FK, Edwards DP, Giam X, Van Der Werf G, Carmenta R, Verwer CC, Gibson L, Gandois L, Graham LL, Regalino J, Wich SA, Rieley J, Kettridge N, Brown C, Pirard R, Moore S, Capilla BR, Ballhorn U, Ho HC, Hoscilo A, Lohberger S, Evans TA, Yulianti N, Blackham G, Onrizal, Husson S, Murdiyarso D, Pangala S, Cole LE, Tacconi L, Segah H, Tonoto P, Lee JS, Schmilewski G, Wulffraat S, Putra EI, Cattau ME, Clymo RS, Morrison R, Mujahid A, Miettinen J, Liew SC, Valpola S, Wilson D, D'Arcy L, Gerding M, Sundari S, Thornton SA, Kalisz B, Chapman SJ, Su AS, Basuki I, Itoh M, Traeholt C, Sloan S, Sayok AK, Andersen R.

Glob Chang Biol. 2017 Mar;23(3):977-982. doi: 10.1111/gcb.13516. Epub 2017 Jan 10. No abstract available.

7.

Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection.

Cole LE, Zhang J, Kesselly A, Anosova NG, Lam H, Kleanthous H, Yethon JA.

Infect Immun. 2016 Mar 24;84(4):1143-1149. doi: 10.1128/IAI.01472-15. Print 2016 Apr.

8.

Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.

Tufariello JM, Chapman JR, Kerantzas CA, Wong KW, Vilchèze C, Jones CM, Cole LE, Tinaztepe E, Thompson V, Fenyö D, Niederweis M, Ueberheide B, Philips JA, Jacobs WR Jr.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E348-57. doi: 10.1073/pnas.1523321113. Epub 2016 Jan 4.

9.

The Complete Genome Sequence of the Emerging Pathogen Mycobacterium haemophilum Explains Its Unique Culture Requirements.

Tufariello JM, Kerantzas CA, Vilchèze C, Calder RB, Nordberg EK, Fischer JA, Hartman TE, Yang E, Driscoll T, Cole LE, Sebra R, Maqbool SB, Wattam AR, Jacobs WR Jr.

MBio. 2015 Nov 17;6(6):e01313-15. doi: 10.1128/mBio.01313-15.

10.

Targeted delivery to bone and mineral deposits using bisphosphonate ligands.

Cole LE, Vargo-Gogola T, Roeder RK.

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):12-27. doi: 10.1016/j.addr.2015.10.005. Epub 2015 Oct 19. Review.

PMID:
26482186
11.

Contrast-Enhanced X-ray Detection of Microcalcifications in Radiographically Dense Mammary Tissue Using Targeted Gold Nanoparticles.

Cole LE, Vargo-Gogola T, Roeder RK.

ACS Nano. 2015 Sep 22;9(9):8923-32. doi: 10.1021/acsnano.5b02749. Epub 2015 Aug 31.

PMID:
26308767
12.

Long-term disturbance dynamics and resilience of tropical peat swamp forests.

Cole LE, Bhagwat SA, Willis KJ.

J Ecol. 2015 Jan;103(1):16-30. Epub 2015 Jan 7.

13.

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.

Santiago AE, Mann BJ, Qin A, Cunningham AL, Cole LE, Grassel C, Vogel SN, Levine MM, Barry EM.

Pathog Dis. 2015 Aug;73(6):ftv036. doi: 10.1093/femspd/ftv036. Epub 2015 May 17.

14.

A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.

Anosova NG, Cole LE, Li L, Zhang J, Brown AM, Mundle S, Zhang J, Ray S, Ma F, Garrone P, Bertraminelli N, Kleanthous H, Anderson SF.

Clin Vaccine Immunol. 2015 Jul;22(7):711-25. doi: 10.1128/CVI.00763-14. Epub 2015 Apr 29.

15.

Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.

Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK.

Nanomedicine (Lond). 2015 Jan;10(2):321-41. doi: 10.2217/nnm.14.171. Review.

PMID:
25600973
16.

Contrast-enhanced X-ray detection of breast microcalcifications in a murine model using targeted gold nanoparticles.

Cole LE, Vargo-Gogola T, Roeder RK.

ACS Nano. 2014 Jul 22;8(7):7486-96. doi: 10.1021/nn5027802. Epub 2014 Jul 11.

PMID:
24992365
17.

Enhanced specialized transduction using recombineering in Mycobacterium tuberculosis.

Tufariello JM, Malek AA, Vilchèze C, Cole LE, Ratner HK, González PA, Jain P, Hatfull GF, Larsen MH, Jacobs WR Jr.

MBio. 2014 May 27;5(3):e01179-14. doi: 10.1128/mBio.01179-14.

18.

Recovery and resilience of tropical forests after disturbance.

Cole LE, Bhagwat SA, Willis KJ.

Nat Commun. 2014 May 20;5:3906. doi: 10.1038/ncomms4906.

19.

Bisphosphonate-functionalized gold nanoparticles for contrast-enhanced X-ray detection of breast microcalcifications.

Cole LE, Vargo-Gogola T, Roeder RK.

Biomaterials. 2014 Feb;35(7):2312-21. doi: 10.1016/j.biomaterials.2013.11.077. Epub 2013 Dec 18.

20.

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN.

Clin Vaccine Immunol. 2014 Feb;21(2):212-26. doi: 10.1128/CVI.00738-13. Epub 2013 Dec 18.

21.

Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.

Anosova NG, Brown AM, Li L, Liu N, Cole LE, Zhang J, Mehta H, Kleanthous H.

J Med Microbiol. 2013 Sep;62(Pt 9):1394-404. doi: 10.1099/jmm.0.056796-0. Epub 2013 Mar 21.

PMID:
23518659
22.

Antigen-specific memory in B-1a and its relationship to natural immunity.

Yang Y, Ghosn EE, Cole LE, Obukhanych TV, Sadate-Ngatchou P, Vogel SN, Herzenberg LA, Herzenberg LA.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5388-93. doi: 10.1073/pnas.1121627109. Epub 2012 Mar 14.

23.

Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Yang Y, Ghosn EE, Cole LE, Obukhanych TV, Sadate-Ngatchou P, Vogel SN, Herzenberg LA, Herzenberg LA.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5382-7. doi: 10.1073/pnas.1121631109. Epub 2012 Mar 14.

24.

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y, Gearhart PJ, Chesko KL, Viscardi RM, Vogel SN.

J Leukoc Biol. 2011 Oct;90(4):787-97. doi: 10.1189/jlb.0111014. Epub 2011 Jul 12.

25.

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA.

Nat Immunol. 2010 May;11(5):395-402. doi: 10.1038/ni.1864. Epub 2010 Mar 28.

26.

Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.

Mohapatra SK, Cole LE, Evans C, Sobral BW, Bassaganya-Riera J, Hontecillas R, Vogel SN, Crasta OR.

BMC Infect Dis. 2010 Jan 18;10:10. doi: 10.1186/1471-2334-10-10.

27.

Vaccines against tularemia.

Barry EM, Cole LE, Santiago AE.

Hum Vaccin. 2009 Dec;5(12):832-8. Epub 2009 Dec 11. Review.

28.

Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Cole LE, Laird MH, Seekatz A, Santiago A, Jiang Z, Barry E, Shirey KA, Fitzgerald KA, Vogel SN.

J Leukoc Biol. 2010 Feb;87(2):275-81. doi: 10.1189/jlb.0909619. Epub 2009 Nov 4.

29.

Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.

Santiago AE, Cole LE, Franco A, Vogel SN, Levine MM, Barry EM.

Vaccine. 2009 Apr 21;27(18):2426-36. doi: 10.1016/j.vaccine.2009.02.073. Epub 2009 Mar 3.

30.

Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.

Cole LE, Yang Y, Elkins KL, Fernandez ET, Qureshi N, Shlomchik MJ, Herzenberg LA, Herzenberg LA, Vogel SN.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4343-8. doi: 10.1073/pnas.0813411106. Epub 2009 Feb 26.

31.

Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.

Shirey KA, Cole LE, Keegan AD, Vogel SN.

J Immunol. 2008 Sep 15;181(6):4159-67.

32.

Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.

Cole LE, Santiago A, Barry E, Kang TJ, Shirey KA, Roberts ZJ, Elkins KL, Cross AS, Vogel SN.

J Immunol. 2008 May 15;180(10):6885-91.

33.

Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.

Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, Elkins KL, Puche AC, Michalek SM, Vogel SN.

Infect Immun. 2007 Aug;75(8):4127-37. Epub 2007 May 21.

34.
35.

Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.

Cole LE, Elkins KL, Michalek SM, Qureshi N, Eaton LJ, Rallabhandi P, Cuesta N, Vogel SN.

J Immunol. 2006 Jun 1;176(11):6888-99.

36.

Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Fulcher RA, Cole LE, Janowicz DM, Toffer KL, Fortney KR, Katz BP, Orndorff PE, Spinola SM, Kawula TH.

Infect Immun. 2006 May;74(5):2651-8.

37.

A humoral immune response confers protection against Haemophilus ducreyi infection.

Cole LE, Toffer KL, Fulcher RA, San Mateo LR, Orndorff PE, Kawula TH.

Infect Immun. 2003 Dec;71(12):6971-7.

38.

The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes.

Cole LE, Kawula TH, Toffer KL, Elkins C.

Infect Immun. 2002 Nov;70(11):6158-65.

39.

Metapsychology and the right to believe.

COLE LE.

Am J Orthopsychiatry. 1951 Jul;21(3):461-71. No abstract available.

PMID:
14857124

Supplemental Content

Support Center